FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044286732> ?p ?o ?g. }

• W2044286732 endingPage "2391" @default.
• W2044286732 startingPage "2391" @default.
• W2044286732 abstract "To evaluate prospectively the efficacy and safety of posterior juxtascleral infusion of a new formulation of triamcinolone acetonide for refractory diffuse diabetic macular edema.This was an interventional case series. Twenty-two consecutive eyes of 18 patients with refractory diffuse diabetic macular edema were included in the study. Each patient underwent a complete ophthalmic examination, including optical coherence tomography (OCT) and digital fluorescein angiography (FA). All patients received a suspension of 40 mg triamcinolone acetonide, 20 mg sodium chondroitin sulfate, and 15 mg sodium hyaluronate (1.5 mL), delivered posteriorly through a conjunctival and Tenon's incision. All patients completed the 1-year follow-up.On average, studied eyes received 1.5 treatments. Mean preoperative foveal thickness (+/-SD) and visual acuity (+/-SD) were 474.2 +/- 136.6 microm and 0.6 +/- 0.37 logarithm of the minimum angle of resolution (logMAR), respectively. The central foveal thickness was significantly reduced from baseline at every follow-up visit (P < 0.001). Mean (+/-SD) reductions in macular thickness were 136 +/- 108 microm at 1 week and 128 +/- 122 microm after 1 year of follow-up. Mean (+/-SD) improvement in visual acuity at 12 months was 0.15 +/- 0.21 logMAR (P = 0.008). Visual acuity improvement of one or more lines and three or more lines were observed in 14 (63.6%) and 6 (27.3%) eyes, respectively. Seven eyes (31.8%) required topical treatment due to a significant intraocular pressure increase.Posterior juxtascleral infusion of a new formulation of triamcinolone acetonide is an effective treatment for diffuse diabetic macular edema unresponsive to conventional grid laser photocoagulation. A randomized, larger study is warranted." @default.
• W2044286732 created "2016-06-24" @default.
• W2044286732 creator A5003374711 @default.
• W2044286732 creator A5015457679 @default.
• W2044286732 creator A5036443714 @default.
• W2044286732 creator A5056909319 @default.
• W2044286732 date "2009-05-01" @default.
• W2044286732 modified "2023-09-29" @default.
• W2044286732 title "Posterior Juxtascleral Infusion of Modified Triamcinolone Acetonide Formulation for Refractory Diabetic Macular Edema: One-Year Follow-Up" @default.
• W2044286732 cites W1485105115 @default.
• W2044286732 cites W1496977463 @default.
• W2044286732 cites W1519861371 @default.
• W2044286732 cites W1556783877 @default.
• W2044286732 cites W1749875967 @default.
• W2044286732 cites W1944606487 @default.
• W2044286732 cites W1971177846 @default.
• W2044286732 cites W1973301470 @default.
• W2044286732 cites W1982807500 @default.
• W2044286732 cites W1984871917 @default.
• W2044286732 cites W1995216352 @default.
• W2044286732 cites W1997950144 @default.
• W2044286732 cites W1998848395 @default.
• W2044286732 cites W2000552582 @default.
• W2044286732 cites W2010804179 @default.
• W2044286732 cites W2016936614 @default.
• W2044286732 cites W2023936996 @default.
• W2044286732 cites W2025417920 @default.
• W2044286732 cites W2026098675 @default.
• W2044286732 cites W2044539046 @default.
• W2044286732 cites W2059265707 @default.
• W2044286732 cites W2059838927 @default.
• W2044286732 cites W2065605189 @default.
• W2044286732 cites W2069618306 @default.
• W2044286732 cites W2071905478 @default.
• W2044286732 cites W2077453997 @default.
• W2044286732 cites W2083092631 @default.
• W2044286732 cites W2101039050 @default.
• W2044286732 cites W2103863709 @default.
• W2044286732 cites W2121182991 @default.
• W2044286732 cites W2128533866 @default.
• W2044286732 cites W2134178766 @default.
• W2044286732 cites W2143779826 @default.
• W2044286732 cites W2147213060 @default.
• W2044286732 cites W2148230234 @default.
• W2044286732 cites W2153916655 @default.
• W2044286732 cites W2159592443 @default.
• W2044286732 cites W2165265638 @default.
• W2044286732 cites W2219174609 @default.
• W2044286732 cites W36944025 @default.
• W2044286732 cites W59239023 @default.
• W2044286732 doi "https://doi.org/10.1167/iovs.08-2518" @default.
• W2044286732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19117937" @default.
• W2044286732 hasPublicationYear "2009" @default.
• W2044286732 type Work @default.
• W2044286732 sameAs 2044286732 @default.
• W2044286732 citedByCount "10" @default.
• W2044286732 countsByYear W20442867322013 @default.
• W2044286732 countsByYear W20442867322014 @default.
• W2044286732 countsByYear W20442867322020 @default.
• W2044286732 countsByYear W20442867322021 @default.
• W2044286732 countsByYear W20442867322023 @default.
• W2044286732 crossrefType "journal-article" @default.
• W2044286732 hasAuthorship W2044286732A5003374711 @default.
• W2044286732 hasAuthorship W2044286732A5015457679 @default.
• W2044286732 hasAuthorship W2044286732A5036443714 @default.
• W2044286732 hasAuthorship W2044286732A5056909319 @default.
• W2044286732 hasBestOaLocation W20442867321 @default.
• W2044286732 hasConcept C118487528 @default.
• W2044286732 hasConcept C134018914 @default.
• W2044286732 hasConcept C141071460 @default.
• W2044286732 hasConcept C2776251621 @default.
• W2044286732 hasConcept C2777917749 @default.
• W2044286732 hasConcept C2778257484 @default.
• W2044286732 hasConcept C2778903070 @default.
• W2044286732 hasConcept C2779829184 @default.
• W2044286732 hasConcept C2780248432 @default.
• W2044286732 hasConcept C2780347916 @default.
• W2044286732 hasConcept C2781092963 @default.
• W2044286732 hasConcept C2985127711 @default.
• W2044286732 hasConcept C555293320 @default.
• W2044286732 hasConcept C71924100 @default.
• W2044286732 hasConceptScore W2044286732C118487528 @default.
• W2044286732 hasConceptScore W2044286732C134018914 @default.
• W2044286732 hasConceptScore W2044286732C141071460 @default.
• W2044286732 hasConceptScore W2044286732C2776251621 @default.
• W2044286732 hasConceptScore W2044286732C2777917749 @default.
• W2044286732 hasConceptScore W2044286732C2778257484 @default.
• W2044286732 hasConceptScore W2044286732C2778903070 @default.
• W2044286732 hasConceptScore W2044286732C2779829184 @default.
• W2044286732 hasConceptScore W2044286732C2780248432 @default.
• W2044286732 hasConceptScore W2044286732C2780347916 @default.
• W2044286732 hasConceptScore W2044286732C2781092963 @default.
• W2044286732 hasConceptScore W2044286732C2985127711 @default.
• W2044286732 hasConceptScore W2044286732C555293320 @default.
• W2044286732 hasConceptScore W2044286732C71924100 @default.
• W2044286732 hasIssue "5" @default.
• W2044286732 hasLocation W20442867321 @default.
• W2044286732 hasLocation W20442867322 @default.

• next